Use of Indium-111–Labeled Hepatocytes to Determine the Biodistribution of Transplanted Hepatocytes Through Portal Vein Infusion
The DOI matches its Crossref record.
Abstract
PURPOSE: Hepatocyte transplantation is useful for ex vivo gene therapy and liver repopulation. Methods for hepatic reconstitution were recently developed, but hepatocyte transplantation systems must be optimized. The authors report their experience with In-111 oxyquinolone labeling of a test dose of hepatocytes (108 cells) for noninvasive assessment of the biodistribution of transplanted hepatocytes in a 5-year-old child with omithine transcarbamoylase deficiency. MATERIALS AND METHODS: Donor hepatocytes (approximately 108) were radiolabeled using a commercially available In-111 oxyquinolone solution (specific activity of 1 mCi/ml). RESULTS: The overall labeling efficiency was 36.4%. A final dose of approximately 290 ,uCi of the In-111-labeled hepatocytes in 10 ml serum-free phosphate-buffered saline was infused percutaneously into the portal vein approximately 2.5 hours after their preparation. The study was performed 3 hours before cell transplantation (109 cells). Quantitative analysis of the biodistribution of In-111-labeled hepatocytes indicated that cells were predominantly localized in the liver immediately after portal vein-infused transplantation. The predominant hepatic distribution was persistent for as long as 7 days after the procedure, with an average liver-to-spleen ratio of 9.5 to 1. No significant pulmonary radiotracer uptake was present. CONCLUSION: These results indicate that In-111 labeling of hepatocytes is useful for the short-term noninvasive analysis of the biodistribution of transplanted hepatocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Aicher, A., Brenner, W., Zuhayra, M., Badorff, C., Massoudi, S., Assmus, B., Eckey, T., Henze, E., Zeiher, A. M., & Dimmeler, S. (2003) · Circulation · doi:10.1161/01.cir.0000062649.63838.c9 · Cited by 559
Human hepatocyte transplantation: current experience and future challenges
Dhawan, A., Puppi, J., Hughes, R. D., & Mitry, R. R. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.44 · Cited by 362
Cell therapy for liver disease: From liver transplantation to cell factory
Forbes, S. J., Gupta, S., & Dhawan, A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.040 · Cited by 325
Human hepatocyte transplantation for liver disease: current status and future perspectives
Iansante, V, Mitry, R. R., Filippi, C., Fitzpatrick, E., & Dhawan, A. (2018) · Pediatric Research · doi:10.1038/pr.2017.284 · Cited by 225
Alternative Cell Sources for Liver Parenchyma Repopulation: Where Do We Stand?
Tricot, T., De Boeck, J., & Verfaillie, C. (2020) · Cells · doi:10.3390/cells9030566 · Cited by 20
Metadata
- Authors
- BOHNEN, N. I., CHARRON, M., REYES, J., RUBINSTEIN, W., STROM, S. C., SWANSON, D., & TOWBIN, R.
- Venue
- Clinical Nuclear Medicine
- Published
- 2000-06
- Volume
- 25
- Issue
- 6
- Pages
- 447-450
- ISSN
- 0363-9762 (ISSN-L)
- OpenAlex
- W2325553041
- Cited by
- 69
- References
- 0
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of Indium-111–Labeled Hepatocytes to Determine the Biodistribution of Transplanted Hepatocytes Through Portal Vein Infusion. https://app.cochat.ai/papers/10.1097/00003072-200006000-00012
- The paper
- BOHNEN, N. I., CHARRON, M., REYES, J., RUBINSTEIN, W., STROM, S. C., SWANSON, D., & TOWBIN, R. (2000). Use of Indium-111–Labeled Hepatocytes to Determine the Biodistribution of Transplanted Hepatocytes Through Portal Vein Infusion. Clinical Nuclear Medicine. https://doi.org/10.1097/00003072-200006000-00012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.